Senvest Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-122,587
Closed -$210K 72
2016
Q3
$210K Sell
122,587
-654,042
-84% -$796K 0.02% 68
2016
Q2
$637K Sell
776,629
-293,531
-27% -$227K 0.05% 63
2016
Q1
$963K Sell
1,070,160
-317,596
-23% -$320K 0.08% 59
2015
Q4
$1.53M Sell
1,387,756
-153,238
-10% -$328K 0.11% 60
2015
Q3
$3.25M Buy
1,540,994
+12,924
+0.8% +$25.2K 0.23% 62
2015
Q2
$3.03M Buy
1,528,070
+365,793
+31% +$1.04M 0.19% 68
2015
Q1
$4.5M Buy
1,162,277
+57,190
+5% +$212K 0.28% 63
2014
Q4
$3.99M Buy
1,105,087
+969,595
+716% +$2.57M 0.28% 53
2014
Q3
$360K Buy
+135,492
New +$906K 0.03% 78

Other funds holding MBII

Senvest Management's MBII Position: Q4 2016 in Review

Senvest Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2016, closing a stake of 122,587 shares — an estimated $210K sold.

Senvest Management first reported a position in MBII in Q3 2014 and held it in 9 quarters. The position peaked at $4.5M in Q1 2015. 23 funds tracked by Wall St. Rank hold MBII as of Q4 2016.

  • Senvest Management reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2016 after selling out during the quarter.
  • Senvest Management sold 122,587 Marrone Bio Innovations, Inc. shares in Q4 2016, an estimated $210K.
  • Senvest Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 9 quarters.
  • Senvest Management's Marrone Bio Innovations, Inc. position peaked at $4.5M in Q1 2015.
  • 23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2016.

Based on Senvest Management's 13F filing for Q4 2016, filed 13 Feb 2017.